MyavA.01331.a
Phosphoglycerate kinase
CENTER ID:
MyavA.01331.a
ORGANISM:
Mycobacterium avium 104
ASSOCIATED DISEASE:
Johne's disease, paratuberculosis
CURRENT STATUS:
in PDB
COMMUNITY REQUEST:
False
NIH RISK GROUP:
2
SELECT AGENT:
False
NIH PRIORITY
pathogens category:
IIIC
Ordering Clones & Proteins
If there are materials available for this target, they will be listed below.
Materials can be ordered from SSGCID using the button in the "order material" column.
Clicking the button will add the material to a virtual cart.
You may order multiple materials at a time at no cost to you, as this contract is funded
by NIAID. When you are ready to place your order, click the "Place Order" link which will
appear in the top right corner of the page after you place your first item in your cart.
Clones*
CENTER
REFERENCE ID
DOMAIN/REGION
DESCRIPTION
INFO
AA
START
AA
STOP
ORDER
MATERIAL
MyavA.01331.a.A1.GE29113
Full length( MyavA.01331.a )
info
1
415
MyavA.01331.a.A1.GE29113
MyavA.01331.a.AE1.GE43236
Full length( MyavA.01331.a )
info
1
415
MyavA.01331.a.AE1.GE43236
* SSGCID clones represent un-induced expression constructs which have been verified by sequencing from vector primers. Clones may contain a tag, such as N-term 6xHis . Get sequence information
using the button in the "info" column.
Proteins
CENTER REFERENCE ID
DOMAIN/REGION DESCRIPTION
INFO
AA START
AA STOP
ORDER MATERIAL
MyavA.01331.a.A1.PW29018
Full length( MyavA.01331.a )
info
1
415
PW29018
MyavA.01331.a.AE1.PW38721
Full length( MyavA.01331.a )
info
1
415
PW38721
Structures
7LA1
DEPOSITED: 1/5/2021
DETERMINATION: XRay
CLONE: MyavA.01331.a.AE1.GE43236
PROTEIN: MyavA.01331.a.AE1.PW38721
Sequences
These sequences are the native gene sequence; sequences of constructs derived from these sequences may differ due to codon optimization or other protocols.
To find the specific sequence of any material you may have ordered, click on the "info" button next to the name of that material.
AA Sequence
MAVHNLKDLL AEGVSGRGVL VRSDLNVPLD SDGEQGRITD PGRITASVPT LSALVEAGAK VVVAAHLGRP KNGPDPALSL APVAAALGEQ LGRHVQLASD VVGTDALARA EGLTDGDVLL LENIRFDARE TSKDDAERLA LARQLAELVG PTGAFVSDGF GVVHRKQASV YDVATLLPHY AGTLVAEEIA VLEQLTGSTK RPYAVVLGGS KVSDKLGVIE SLATKADSIV IGGGMCFTFL AAQGFSVGKS LLETEMVDTC RRLLDTYVDV LRLPVDIVAA DRFAADAAPQ TVPADAIPDD LMGLDIGPGS VKRFTALLSN AETIFWNGPM GVFEFPAFAA GTKGLAEAIA AATGKGAFSV VGGGDSAAAV RALGIPESGF SHISTGGGAS LEYLEGKALP GIEVLGRPQP TGGAA
NT Sequence
GTGGCTGTCC ACAATCTCAA AGACCTTCTC GCCGAAGGTG TTTCCGGACG CGGTGTGCTG GTGCGTTCGG ACCTGAACGT GCCGCTGGAC TCCGATGGTG AGCAAGGCCG GATCACCGAC CCCGGCCGGA TCACCGCGTC GGTGCCGACG TTGAGCGCAC TGGTCGAGGC GGGCGCCAAG GTGGTGGTCG CCGCGCACCT CGGGCGTCCC AAGAATGGGC CGGACCCGGC GTTGTCGCTG GCCCCGGTGG CCGCCGCGCT CGGCGAGCAG CTGGGCCGGC ACGTGCAGCT GGCCTCGGAC GTGGTGGGCA CCGACGCCCT GGCCCGCGCC GAGGGGTTGA CCGACGGCGA CGTCCTGCTG CTGGAAAACA TCCGGTTCGA CGCCCGCGAA ACGTCCAAGG ACGACGCCGA GCGGCTCGCG CTGGCCCGGC AGCTGGCCGA ATTGGTCGGT CCCACAGGCG CTTTCGTCTC CGACGGTTTC GGCGTGGTGC ACCGCAAGCA GGCCTCGGTG TACGACGTCG CCACGCTGCT GCCGCACTAC GCCGGCACGC TGGTGGCCGA GGAGATCGCC GTGCTGGAGC AGCTGACCGG CTCGACCAAA CGCCCCTACG CGGTGGTGCT CGGCGGGTCC AAGGTGTCCG ACAAGCTCGG CGTCATCGAG TCGCTGGCCA CCAAGGCCGA CAGCATCGTC ATCGGCGGCG GCATGTGCTT CACCTTTCTT GCTGCGCAAG GGTTTTCGGT TGGTAAGTCG CTGCTAGAAA CCGAGATGGT GGACACCTGC CGCCGGCTGC TGGACACCTA CGTCGACGTG CTGCGGCTGC CGGTGGACAT CGTGGCGGCC GACAGGTTCG CCGCCGACGC GGCGCCGCAG ACCGTGCCGG CCGACGCCAT CCCCGACGAC CTGATGGGCC TGGACATCGG GCCGGGATCG GTCAAGAGGT TCACCGCGCT GCTGTCCAAC GCCGAGACGA TCTTCTGGAA CGGCCCGATG GGCGTGTTCG AGTTCCCGGC GTTCGCCGCG GGCACCAAGG GCCTGGCCGA AGCGATCGCC GCGGCGACCG GCAAGGGCGC CTTCTCCGTG GTCGGCGGCG GCGACTCGGC GGCCGCGGTG CGCGCGCTGG GCATCCCGGA GAGCGGCTTC TCGCACATTT CCACCGGCGG CGGGGCGTCG CTGGAATACC TTGAGGGCAA GGCACTTCCG GGCATCGAGG TGCTGGGACG TCCGCAACCG ACGGGAGGCG CCGCG
Details for MyavA.01331.a.A1.GE29113
HARVESTED ON:
4/27/2010
SEQUENCED ON:
5/1/2010
EXPECTED MW:
44kDa
OBSERVED MW:
45kDa
ANTIBIOTIC MARKER:
ampicillin
COUNT OF EXPRESSION COLONIES:
Too many to count (100+)
TOTAL EXPRESSION LEVEL:
Low Expression
SOLUBLE EXPRESSION LEVEL
Moderate Expression
EXPRESSION HOST:
data unavailable
SEQUENCING RESULT:
pass
PERCENT IDENTITY:
100
PERCENT COVERAGE:
95
Details for MyavA.01331.a.AE1.GE43236
HARVESTED ON:
6/12/2019
SEQUENCED ON:
6/18/2019
EXPECTED MW:
43kDa
OBSERVED MW:
43kDa
ANTIBIOTIC MARKER:
ampicillin
COUNT OF EXPRESSION COLONIES:
Good (10-50)
TOTAL EXPRESSION LEVEL:
Moderate Expression
SOLUBLE EXPRESSION LEVEL
Moderate Expression
EXPRESSION HOST:
BL 21 (DE3) Rosetta
SEQUENCING RESULT:
PERCENT IDENTITY:
100
PERCENT COVERAGE:
44
Details for MyavA.01331.a.A1.PW29018
PURIFICATION DATe:
7/13/2010
CONCENTRATION:
26.5mg/ml
OBSERVED MW:
data unavailable
EXPRESSION LEVEL:
Moderate Expression
PROTEIN PURIFICATION BUFFER:
25 mM HEPES pH 7.0, 500 mM NaCl, 5% Glycerol , 2 mM DTT, and 0.025% Azide
EXPRESSION HOST:
data unavailable
VIAL COUNT (approx.):
3
VIAL VOLUME:
200µl
PERCENT IDENTITY:
100
PERCENT COVERAGE:
95
Details for MyavA.01331.a.AE1.PW38721
PURIFICATION DATe:
10/17/2019
CONCENTRATION:
8.6mg/ml
OBSERVED MW:
42kDa
EXPRESSION LEVEL:
Moderate Expression
PROTEIN PURIFICATION BUFFER:
25 mM HEPES pH 7.0, 500 mM NaCl, 5% Glycerol, 2 mM DTT, 0.025% Azide
EXPRESSION HOST:
BL 21 (DE3) Rosetta
VIAL COUNT (approx.):
3
VIAL VOLUME:
200µl
PERCENT IDENTITY:
100
PERCENT COVERAGE:
44